abstract |
ovel compounds are disclosed, which are derivatives of 1, 2, 3, 5, 6, 10b-hexahydropyrrolo [2, 1-a]- isoquinolines, represented by general formula (I):n as well as pharmaceutical compositions and methods for the treatment of depression in warm-blooded animals, e.g., man. Novel intermediates are also part of the invention. |